| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |